The issue of ‘chemo-brain’ — cognitive impairment following chemotherapy — has been a controversial one. While it is now (I hope) accepted by most that it is, indeed, a real issue, there is still an ongoing debate over whether the main cause is really the chemotherapy. A new study adds to the debate.
Latest Research News
New research suggests that reliance on the standard test Alzheimer's Disease Assessment Scale—Cognitive Behavior Section (ADAS-Cog) to measure cognitive changes in Alzheimer’s patients is a bad idea. The test is the most widely used measure of cognitive performance in clinical trials.
Being a woman of a certain age, I generally take notice of research into the effects of menopause on cognition. A new study adds weight, perhaps, to the idea that cognitive complaints in perimenopause and menopause are not directly a consequence of hormonal changes, but more particularly, shows that early post menopause may be the most problematic time.
Sad to say, another large study has given the thumbs down to ginkgo biloba preventing Alzheimer’s disease.
The randomized, double-blind trial took place over five years, involving 2854 older adults (70+) who had presented to their primary care physician with memory complaints. Half were given a twice-daily dose of 120 mg standardised ginkgo biloba extract and half a placebo.
In my book on remembering intentions, I spoke of how quickly and easily your thoughts can be derailed, leading to ‘action slips’ and, in the wrong circumstances, catastrophic mistakes. A new study shows how a 3-second interruption while doing a task doubled the rate of sequence errors, while a 4s one tripled it.
Organophosphate pesticides are the most widely used insecticides in the world; they are also (according to WHO), one of the most hazardous pesticides to vertebrate animals. While the toxic effects of high levels of organophosphates are well established, the effects of long-term low-level exposure are still controversial.
An online study open to anyone, that ended up involving over 100,000 people of all ages from around the world, put participants through 12 cognitive tests, as well as questioning them about their background and lifestyle habits. This, together with a small brain-scan data set, provided an immense data set to investigate the long-running issue: is there such a thing as ‘g’ — i.e. is intelligence accounted for by just a single general factor; is it supported by just one brain network? — or are there multiple systems involved?
Previous research has pointed to an association between not having teeth and a higher risk of cognitive decline and dementia. One reason might have to do with inflammation — inflammation is a well-established risk factor, and at least one study has linked gum disease to a higher dementia risk. Or it might have to do with the simple mechanical act of chewing, reducing blood flow to the brain. A new study has directly investigated chewing ability in older adults.
I’ve spoken before about the effects of motivation on test performance. This is displayed in a fascinating study by researchers at the Educational Testing Service, who gave one of their widely-used tests (the ETS Proficiency Profile, short form, plus essay) to 757 students from three institutions: a research university, a master's institution and a community college. Here’s the good bit: students were randomly assigned to groups, each given a different consent form.
A review of 25 major studies investigating the value of sensory integration therapy (SIT) for autistic children has concluded that this most popular of therapies has no scientific support.
Only three of the 25 studies found benefits from SIT, and these three all had serious methodological flaws. Eight of the studies found mixed results, while 14 studies reported no benefits. Many of the reviewed studies had serious methodological flaws.